In human genetic studies, it was found that serotonin mediation in CNS is responsible for the development of metabolic syndrome, insulin resistance, and type 2 diabetes, as it is associated with polymorphism in SERT genes [36]. This evidence concerns the gene SLC6A4 and type 2 diabetes mellitus.